Exploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (Unesp)-
Autor(es): dc.creatorSábio, Rafael Miguel [UNESP]-
Autor(es): dc.creatorMeneguin, Andréia Bagliotti [UNESP]-
Autor(es): dc.creatorMartins dos Santos, Aline [UNESP]-
Autor(es): dc.creatorMonteiro, Andreia Sofia [UNESP]-
Autor(es): dc.creatorChorilli, Marlus [UNESP]-
Data de aceite: dc.date.accessioned2022-02-22T00:52:56Z-
Data de disponibilização: dc.date.available2022-02-22T00:52:56Z-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2020-12-31-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1016/j.micromeso.2020.110774-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/208277-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/208277-
Descrição: dc.descriptionThe exploitation of mesoporous silica nanoparticles (MSNs) as drug delivery systems has grown exponentially due to their remarkable tunable properties, such as high surface area, chemical and physical stability, high loading and release capacities, distinct possibilities of particle and pore structures, as well as good biocompatibility, biodegradability, and easy clearance. However, the main exposure routes that exploit MSNs qualities, namely intravenous, subcutaneous, intramuscular, intratumoral, ophthalmic, pulmonary, nasal, dermal, and oral administrations, have been underreported to date. In addition, a better understanding of these administration routes can contribute to the development of smart MSNs-based nanoplatforms with interesting properties, such as high stability in physiological media, specificity and efficacy in theranostic applications, and further clinical translations. This review highlights the advantages and challenges of the administration routes aforementioned regarding the MSNs as drug delivery systems. It also shows how their properties can influence the interaction with biological media, and consequently, their biocompatibility, biodistribution, and clearance mostly in pre-clinical assays, in order to contribute to further MSNs-based nanoplatform clinical translations.-
Descrição: dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
Descrição: dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences - São Paulo State University (UNESP)-
Descrição: dc.descriptionInstitute of Chemistry - São Paulo State University (UNESP)-
Descrição: dc.descriptionSchool of Pharmaceutical Sciences - São Paulo State University (UNESP)-
Descrição: dc.descriptionInstitute of Chemistry - São Paulo State University (UNESP)-
Descrição: dc.descriptionCNPq: # 465687/2014-8-
Descrição: dc.descriptionFAPESP: #18/25377-3-
Descrição: dc.descriptionFAPESP: #2014/50928-2-
Idioma: dc.languageen-
Relação: dc.relationMicroporous and Mesoporous Materials-
???dc.source???: dc.sourceScopus-
Palavras-chave: dc.subjectAdministration routes-
Palavras-chave: dc.subjectBiological behavior-
Palavras-chave: dc.subjectDrug delivery systems-
Palavras-chave: dc.subjectMesoporous silica nanoparticles (MSNs)-
Título: dc.titleExploiting mesoporous silica nanoparticles as versatile drug carriers for several routes of administration-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.